A Phase 2 Study of SNA-125 for the Treatment of Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2018
At a glance
- Drugs SNA 125 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Sienna Biopharmaceuticals
- 03 Dec 2018 According to a Sienna Biopharmaceuticals media release, the company plans to initiate this phase 2 study with SNA-125 in atopic dermatitis in the second half of 2019.
- 10 Sep 2018 New trial record
- 27 Aug 2018 According to a Sienna Biopharmaceuticals media release, this study is expected in the 2019.